Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYD dengue vaccine booster study in previously vaccinated adolescents and adults
2019-000993-44Phase 2
- Sponsor
- Sanofi
- Start
- Jun 2019
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dengue fever comparing CYD dengue vaccine booster with Placebo (2 arms). Primary endpoint: Neutralizing antibody levels after prior third dose and after booster.
02
Drugs
CYD dengue vaccine
03
Conditions
dengue fever
Beyond the preview
Go deeper on 2019-000993-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000993-44.